Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Company Information
About this company
Key people
Michael Akoh
Chief Executive Officer
Borge Sorvoll
Chief Financial Officer
Darren Ellis
Chief Scientific Officer
Olav Lanes
Vice President - Applications, Research and Development
Marit Sjo Lorentzen
Operations Director, Director - Employee Elected
Volker Wedershoven
Director
Click to see more
Key facts
- Shares in issue51.07m
- EPICAZT
- ISINNO0010014632
- LocationNorway
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capNOK 1.14bn
- Employees55
- ExchangeOslo Stock Exchange
- IndexOSL All-share Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.